| Literature DB >> 32606821 |
Chao Liu1,2, Pengcheng Du3, Jiankang Zhao2, Binbin Li2, Chunlei Wang2, Lingxiao Sun2,4, Binghuai Lu2, Yimin Wang2, Yingmei Liu2, Bin Cao1,2,4,5,6.
Abstract
BACKGROUND: Multidrug-resistant (MDR) ST11 hypervirulent Klebsiella pneumoniae (hvKp) is emerging in China.Entities:
Keywords: community-acquired infection; hospital-acquired infection; hypervirulent Klebsiella pneumoniae; multidrug resistance; whole-genome sequencing
Year: 2020 PMID: 32606821 PMCID: PMC7293908 DOI: 10.2147/IDR.S243836
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Clinical Characteristics of Patients with Klebsiella pneumonia Infection
| Patient | Age | Sex | Specimen | Collection Date | Department | Immunosuppression | Antibiotic Agent Exposure | Intubation | HAI | Type of Infection | APACHE II | SOFA | CCI | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Z1 | 78 | M | Sputum | 20171218 | Respiratory-N | N | Y | Y | Y | VAP | Y | Y | 6 | Survive |
| Z3 | 60 | M | Sputum | 20180101 | Respiratory-H | Y | Y | Y | Y | Pneumonia | Y | Y | 3 | Survive |
| Z4 | 48 | M | Tissue | 20180103 | Respiratory-H | Y | Y | Y | Y | Pneumonia | Y | Y | 4 | Survive |
| Z5 | 73 | F | Urine | 20180104 | Gastroenterology-H | N | Y | Y | Y | UTI | Y | N | 3 | Death |
| Z6 | 37 | M | BALF | 20180104 | Respiratory-H | N | Y | Y | Y | VAP | N | Y | 1 | Survive |
| Z7 | 87 | M | Sputum | 20180108 | SICU | Y | Y | Y | Y | VAP | Y | Y | 4 | Survive |
| Z9 | 57 | F | Tissue | 20180112 | Respiratory-H | Y | Y | N | Y | Pneumonia | N | N | 3 | Survive |
| Z10 | 35 | M | Sputum | 20180115 | Internal Medicine | N | Y | Y | Y | VAP | N | N | 3 | Survive |
| Z12 | 80 | M | Sputum | 20180121 | Respiratory-N | Y | Y | Y | Y | Pneumonia | Y | Y | 6 | Survive |
| Z13 | 82 | F | Sputum | 20180122 | Respiratory-N | N | Y | Y | Y | Pneumonia | N | Y | 3 | Survive |
| Z14 | 44 | F | BALF | 20180122 | Respiratory-H | Y | Y | Y | Y | VAP | N | Y | 1 | Death |
| Z15 | 87 | F | Urine | 20180201 | Respiratory-N | N | Y | N | Y | CAUTI | Y | Y | 4 | Survive |
| Z17 | 42 | F | Drainage liquid | 20180208 | SICU | Y | Y | Y | Y | Pneumonia | N | Y | 4 | Death |
| Z18 | 35 | M | BALF | 20180211 | Respiratory-H | Y | Y | Y | Y | VAP | Y | Y | 4 | Death |
| Z19 | 80 | M | Sputum | 20180213 | SICU | Y | Y | Y | Y | VAP | Y | Y | 14 | Death |
| Z20 | 28 | M | Sputum | 20180224 | Respiratory-H | Y | Y | Y | Y | VAP | N | N | 1 | Death |
| Z21 | 84 | F | Sputum | 20180218 | Respiratory-H | N | Y | N | CAI | Pneumonia | N | N | 1 | Survive |
| Z22 | 87 | F | Urine | 20180221 | Respiratory-N | N | Y | Y | Y | CAUTI | Y | Y | 4 | Death |
| Z23 | 81 | M | Urine | 20180222 | Nephrology-N | Y | Y | Y | Y | CAUTI | Y | Y | 4 | Death |
| Z24 | 86 | F | Urine | 20180224 | General Medicine-N | N | Y | Y | Y | UTI | Y | N | 5 | Survive |
| Z25 | 83 | F | Sputum | 20180309 | SICU | Y | Y | Y | Y | Pneumonia | Y | Y | 5 | Survive |
| Z26 | 70 | F | Sputum | 20180310 | Respiratory-N | Y | Y | Y | Y | VAP | Y | Y | 5 | Death |
| Z27 | 68 | M | Sputum | 20180315 | SICU | N | Y | Y | Y | VAP | Y | Y | 2 | Death |
| Z28 | 35 | M | Sputum | 20180317 | Neurology-N | Y | Y | Y | Y | Pneumonia | Y | N | 2 | Survive |
| Z29 | 76 | M | BALF | 20180417 | Respiratory-H | Y | Y | Y | Y | VAP | Y | N | 6 | Survive |
| Z31 | 58 | F | BALF | 20180427 | Respiratory-N | N | Y | Y | Y | Pneumonia | N | N | 2 | Death |
| Z32 | 28 | F | Blood | 20170618 | Respiratory-N | Y | Y | Y | Y | BSI | Y | Y | 4 | Death |
| Z33 | 58 | M | Sputum | 20180517 | Respiratory-H | Y | Y | Y | Y | VAP | Y | N | 3 | Survive |
| Z35 | 78 | F | BALF | 20180529 | Respiratory-H | N | Y | Y | Y | VAP | Y | Y | 2 | Death |
| Z36 | 78 | M | Sputum | 20180614 | Respiratory-N | N | Y | Y | Y | Pneumonia | Y | Y | 4 | Death |
| Z37 | 78 | F | BALF | 20180617 | Respiratory-H | N | Y | Y | CAI | VAP | N | Y | 6 | Death |
| Z38 | 57 | F | Urine | 20180618 | CCU | N | Y | Y | Y | CAUTI | Y | Y | 5 | Survive |
| Z39 | 90 | F | Sputum | 20180110 | Respiratory-N | N | Y | Y | Y | Pneumonia | N | Y | 4 | Survive |
Note: **Withheld life-sustainable treatment; The -H and -N department means headquarters and north campus, respectively.
Abbreviations: CAI, community-acquired infection; HAI, hospital-acquired infection; BALF, bronchoalveolar lavage fluid; CAUTI, catheter-associated urinary tract infection; VAP, ventilator-associated pneumonia; BSI, bloodstream infection; UTI, urinary tract infection; SICU, surgery intensive care medicine; CCU, cardiac intensive care unit. Y, yes; N, no.
Figure 1Phylogenetic tree of MDR-Kp strains. Brown: positive. Green: hospital-acquired infection. Purple: community-acquired infection. Blue: KL47. Pink: KL64. Hypervirulent phenotype: G mellonella mortality is not lower than the reference strain (K1-hvKp) at 48 h.
Figure 2Evolutionary and transmission map of isolated Kp strains. Brown: clade 1 strains. Green: clade 2a strains. Blue: clade 2b strains. Black circle, ancestral strain determined by SNP analysis. Gray, strains during transmission not captured in this study. Red numbers, hvKp defined by the combination of five key virulence genes. The numbers on the arrows are SNPs.